Close

Cassava Sciences's (SAVA) Simufilam Improves Cognition and Behavior in Alzheimer’s Disease in Interim Analysis of Open-label Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/26/2024

1. META
2. GOOGL
3. CMG
4. MSFT
5. LRCX
6. IBM
7. SPY
8. INTC
9. SNAP
10. BA


Go back to Cassava Sciences's (SAVA) Simufilam Improves Cognition and Behavior in Alzheimer’s Disease in Interim Analysis of Open-label Study

Cassava Sciences (SAVA) Hits Low, Down 24%

February 4, 2021 2:29 PM EST

Cassava Sciences (NASDAQ: SAVA) Hits Low, Down 24%

... More

Cassava Sciences (SAVA) Extends Earlier Gain, Up Another 30%

February 3, 2021 5:05 PM EST

Cassava Sciences (NASDAQ: SAVA) Extends Earlier Gain, Up Another 30%

Closed up 59%
... More

Cassava Sciences (SAVA) Hits High, Up Over 30%

February 3, 2021 11:45 AM EST

Cassava Sciences (NASDAQ: SAVA) Hits High, Up Over 30%

... More

Cassava Sciences (SAVA) Extends Gain, Up 205%

February 2, 2021 1:58 PM EST

Cassava Sciences (NASDAQ: SAVA) Extends Gain, Up 205%

... More

Cassava Sciences (SAVA) to Resume Trading at 9 a.m.

February 2, 2021 8:35 AM EST

Cassava Sciences (NASDAQ: SAVA) to Resume Trading at 9 a.m.

... More